VLS Semaglutide 5mg Injection Pen

VLS Semaglutide 5 mg Injection Pen – GLP-1 Support for Blood Sugar and Weight Management

VLS Semaglutide 5 mg Injection Pen is a pre-filled injection pen listed as containing a total of Semaglutide 5 mg in 3 mL, equivalent to approximately 1.66 mg/ml. Semaglutide belongs to a group of medicines known as glucagon-like peptide-1 receptor agonists, also called GLP-1 receptor agonists. It helps regulate appetite, slows gastric emptying, supports glucose-dependent insulin release, and reduces inappropriate glucagon secretion. The pre-filled pen is designed for subcutaneous administration and is commonly supplied with four disposable needles. The exact selectable dose settings and number of doses should be confirmed from the original pen and carton.

Key Features

• Contains Semaglutide: A long-acting GLP-1 receptor agonist.
• 5 mg Total Content: Listed as containing 5 mg of semaglutide in a 3 ml pre-filled pen.
• Pre-Filled Pen: Ready-to-use presentation without manual vial reconstitution.
• Adjustable Pen Format: Available listings describe multiple selectable dose settings.
• Needles Included: Commonly supplied with four disposable pen needles.
• Subcutaneous Administration: Designed for injection under the skin.

Active Ingredient

• Semaglutide 5 mg in 3 mL: A GLP-1 receptor agonist that supports appetite regulation and glucose control.

Product Details

• Product Name: VLS Semaglutide Injection Pen.
• Total Listed Strength: 5 mg.
• Listed Pen Volume: 3 ml.
• Approximate Concentration: 1.66 mg/ml.
• Dosage Form: Pre-filled multidose injection pen.
• Route of Administration: Subcutaneous injection.
• Pack Contents: One pre-filled pen with four disposable needles, according to available listings.

Uses

• Supports blood-glucose management in adults with type 2 diabetes when appropriately prescribed.
• Supports appetite regulation and reduced calorie intake.
• May support medically supervised weight management alongside diet and physical activity.

How to Use

• Use only as directed by a qualified healthcare professional.
• Confirm the prescribed dose on the pen before every injection.
• Inject under the skin of the abdomen, thigh, or upper arm.
• Do not inject it into a vein or muscle.
• Rotate the injection site with every administration.
• Attach a new compatible disposable needle before every injection.
• Check that the solution is clear and colourless before use.
• Remove and safely discard the needle immediately after administration.
• Never share the injection pen or needles with another person.
• Do not determine the dose by counting clicks unless the original instructions specifically provide a validated click-based dosing guide.

Possible Side Effects

• Nausea.
• Vomiting.
• Diarrhoea.
• Constipation.
• Abdominal pain or discomfort.
• Indigestion, bloating, or increased gas.
• Reduced appetite.
• Headache or dizziness.
• Fatigue.
• Injection-site irritation.

Storage

• Store the unused pen in a refrigerator between 2°C and 8°C.
• Do not freeze.
• Keep the pen away from the refrigerator’s cooling element.
• Protect it from excessive heat and direct sunlight.
• Keep the pen cap attached when it is not being used.
• Do not store the pen with a needle attached.
• Follow the original packaging for the permitted storage period after first use.
• Do not use if the solution appears cloudy, discoloured, or contains visible particles.
• Keep out of reach of children.

Legal Disclaimer: The exact manufacturer-authorized dose settings, approved indication, number of doses, and storage period after first use could not be verified from an official VLS product leaflet. Confirm all details from the original carton and pen label. This information is provided for general product-information purposes and should not replace professional medical advice or the instructions supplied with the product.